Changes in the estimated glomerular filtration rate and predictors of the renal prognosis in Japanese patients with type 2 diabetes: A retrospective study during the 12 months after the initiation of tofogliflozin.
Hiroyuki ItoHideyuki InoueTakuma IzutsuSuzuko MatsumotoShinichi AntokuTomoko YamasakiToshiko MoriMichiko ToganePublished in: PloS one (2023)
Tofogliflozin may preserve renal function in the medium term in patients with type 2 diabetes and kidney impairment without an increase in specific adverse events.